Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 2Other neoplasm 1

Conditions

Stomach Neoplasms 2

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 54Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Human Papillomavirus DNA Tests × Gastrointestinal × Clear all
NCT07026240 2025-06-18

Post-operative Monitoring of Gastric Cancer

Suzhou Huhu Health & Technology Inc.

Recruiting
258 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06232395 2025-06-06

Early Detection and Post-operative Monitoring of Gastric Cancer

Suzhou Huhu Health & Technology Inc.

Recruiting
1,197 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡